Dr. Amy Hazen, shown with her husband Josh, celebrates her successful defense on February 19, 2009. Dr. Hazen has recently become the Associate Director for Shared Research Resources at the University of Texas Health Science Center in Houston; she had previously been the Associate Director for the Flow Cytometry Research Core, also at UT, Houston.
Dr. Hazen's publication record while in the Program:
Desponts C, Hazen A, Paraiso K, Kerr W. SHIP deficiency enhances HSC proliferation and survival but compromises homing and repopulation. Blood 2006; 107 4338-4345.
Hazen AL, Smith MJ, Desponts C, Winter O, Moser K, Kerr WG. SHIP is required for a functional hematopoietic stem cell niche. Blood. 2009 Mar 26;113(13):2924-33. Epub 2008 Dec 12.
Dr. Hazen's publication record since graduation:
Collazo MM, Paraiso KH, Park MY, Hazen AL, Kerr WG. Lineage extrinsic and intrinsic control of immunoregulatory cell numbers by SHIP. Eur J Immunol. 2012 Jul;42(7):1785-95. doi: 10.1002/eji.201142092. PMID: 22535653
Hazen AL, Diks SH, Wahle JA, Fuhler GM, Peppelenbosch MP, Kerr WG. Major remodelling of the murine stem cell kinome following differentiation in the hematopoietic compartment. J Proteome Res. 2011 Aug 5;10(8):3542-50.
Abbas HA, Maccio DR, Coskun S, Jackson JG, Hazen AL, Sills TM, You MJ, Hirschi KK, Lozano G. Mdm2 is required for survival of hematopoietic stem cells/progenitors via dampening of ROS-induced p53 activity. Cell Stem Cell. 2010 Nov 5;7(5):606-17.